The contribution of NEAT1 to cancer progression has also been studied in other cancers, including cervical cancer [77], cholangiocarcinoma [78], endometrial cancer [79], esophageal carcinoma [80], gallbladder cancer [81], glioblastoma [82], Hodgkin’s lymphoma [83], laryngeal carcinoma [84], melanoma [85], multiple myeloma [11], nasopharyngeal carcinoma [86], osteosarcoma [87], pancreatic carcinoma [88], retinoblastoma [89], thyroid cancer [90], and tongue carcinoma [91]. Here, NEAT1 is linked to glioblastoma.